BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22517656)

  • 1. A sweet new role for ubiquitin-specific protease 2 in controlling hepatic gluconeogenesis.
    Finck BN
    Diabetes; 2012 May; 61(5):993-4. PubMed ID: 22517656
    [No Abstract]   [Full Text] [Related]  

  • 2. Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1.
    Molusky MM; Li S; Ma D; Yu L; Lin JD
    Diabetes; 2012 May; 61(5):1025-35. PubMed ID: 22447855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog.
    Edgerton DS; Basu R; Ramnanan CJ; Farmer TD; Neal D; Scott M; Jacobson P; Rizza RA; Cherrington AD
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1019-26. PubMed ID: 20159854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stress on hepatic 11beta-hydroxysteroid dehydrogenase activity and its influence on carbohydrate metabolism.
    Altuna ME; Lelli SM; San Martín de Viale LC; Damasco MC
    Can J Physiol Pharmacol; 2006 Oct; 84(10):977-84. PubMed ID: 17218963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1.
    Fan Z; Du H; Zhang M; Meng Z; Chen L; Liu Y
    Mol Cell Endocrinol; 2011 Feb; 333(1):62-9. PubMed ID: 21163329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal protein restriction leads to enhanced hepatic gluconeogenic gene expression in adult male rat offspring due to impaired expression of the liver X receptor.
    Vo TX; Revesz A; Sohi G; Ma N; Hardy DB
    J Endocrinol; 2013 Jul; 218(1):85-97. PubMed ID: 23633563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of glucose homeostasis by glycyrrhizic acid through gluconeogenesis rate-limiting enzymes.
    Chia YY; Liong SY; Ton SH; Kadir KB
    Eur J Pharmacol; 2012 Feb; 677(1-3):197-202. PubMed ID: 22227336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.
    Yao F; Chen L; Fan Z; Teng F; Zhao Y; Guan F; Zhang M; Liu Y
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4107-4113. PubMed ID: 28751144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary iron, circadian clock, and hepatic gluconeogenesis.
    Kalhan SC; Ghosh A
    Diabetes; 2015 Apr; 64(4):1091-3. PubMed ID: 25805759
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
    Kurano M; Hara M; Satoh H; Tsukamoto K
    Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting.
    Kaneko K; Soty M; Zitoun C; Duchampt A; Silva M; Philippe E; Gautier-Stein A; Rajas F; Mithieux G
    Mol Metab; 2018 Oct; 16():203-212. PubMed ID: 29960865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisomal localization and circadian regulation of ubiquitin-specific protease 2.
    Molusky MM; Ma D; Buelow K; Yin L; Lin JD
    PLoS One; 2012; 7(11):e47970. PubMed ID: 23133608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of superoxide dismutase overexpression on hepatic gluconeogenesis and whole-body glucose oxidation during resuscitated normotensive murine septic shock.
    Simkova V; Baumgart K; Vogt J; Wachter U; Weber S; Gröger M; Speit G; Radermacher P; Albuszies G; Barth E
    Shock; 2008 Nov; 30(5):578-84. PubMed ID: 18317403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice.
    Du H; Liu L; Wang Y; Nakagawa Y; Lyzlov A; Lutfy K; Friedman TC; Peng X; Liu Y
    J Mol Endocrinol; 2013 Apr; 50(2):167-78. PubMed ID: 23267038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
    Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
    Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism during exercise in man: the role of insulin and glucagon in the regulation of hepatic glucose production and gluconeogenesis.
    Lavoie C; Ducros F; Bourque J; Langelier H; Chiasson JL
    Can J Physiol Pharmacol; 1997 Jan; 75(1):26-35. PubMed ID: 9101062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
    Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice.
    Wang L; Tong X; Gu F; Zhang L; Chen W; Cheng X; Xie L; Chang Y; Zhang H
    J Biol Chem; 2017 Dec; 292(52):21631-21642. PubMed ID: 29123026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles.
    Woitiski CB; Neufeld RJ; Soares AF; Figueiredo IV; Veiga FJ; Carvalho RA
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1441-50. PubMed ID: 22324290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.